Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 138 (97th)

Obstetric Care Information Act

referredUnited States· United States Congress· EN

Introduced

5 January 1981

Last action

6 February 1981 · Referred

Status

Referred to Subcommittee on Health and the Environment.

Sponsors

Rep. Bingham, Jonathan B. [D-NY-22], Rep. Addabbo, Joseph P. [D-NY-6], Rep. Atkinson, Eugene V. [D-PA-25], Rep. Bonior, David E. [D-MI-10], Rep. Chisholm, Shirley [D-NY-12], Rep. Clay, William (Bill) [D-MO-1], Rep. Coelho, Anthony Lee [D-CA-15], Rep. Collins, Cardiss [D-IL-7], Rescom. Corrada, Baltasar [I-PR-At Large], Rep. Crockett, George W., Jr. [D-MI-13], Del. de Lugo, Ron [D-VI-At Large], Rep. Dellums, Ronald V. [D-CA-9], Rep. Downey, Thomas J. [D-NY-2], Del. Fauntroy, Walter E. [D-DC-At Large], Rep. Ferraro, Geraldine A. [D-NY-9], Rep. Frank, Barney [D-MA-4], Rep. Kildee, Dale E. [D-MI-5], Rep. Lehman, William [D-FL-17], Sen. Markey, Edward J. [D-MA], Sen. Mikulski, Barbara A. [D-MD], Rep. Miller, George [D-CA-11], Rep. Mitchell, Parren J. [D-MD-7], Rep. Patterson, Jerry M. [D-CA-38], Rep. Pepper, Claude [D-FL-18], Rep. Pritchard, Joel [R-WA-1], Rep. Scheuer, James H. [D-NY-8], Rep. Schroeder, Patricia [D-CO-1], Rep. Seiberling, John F. [D-OH-14], Rep. Shamansky, Bob [D-OH-12], Rep. Solarz, Stephen J. [D-NY-13], Rep. Stokes, Louis [D-OH-11], Rep. Washington, Harold [D-IL-1], Rep. Walgren, Doug [D-PA-18], Rep. Weaver, James H. [D-OR-4], Rep. Weber, Vin [R-MN-2]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Official sourceView documentsShare

Summary

Obstetric Care Information Act - Amends title V (Maternal and Child Health) of the Social Security Act to require a State plan under such title to insure that a pregnant woman: (1) has the opportunity, upon her request, to inspect, copy, and have explained any medical records relating to her condition or treatment; (2) is informed, beforehand, of the side effects, risks, contraindications, and effectiveness of the procedures, drugs or devices, and of alternative methods of treatment; and (3) consents to treatment. Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish guidelines with respect to the explanation of the side effects, risks, contraindications, and effectiveness of drugs and devices intended for use by pregnant women. Deems misbranded any drug or device offered for sale to a woman for use during pregnancy or parturition which does not meet such guidelines. Directs the Secretary to arrange for a study to determine the long-term side effects, risks, contraindications, and effectiveness of the use of obstetrical drugs, devices, and procedures with respect to maternal health and child development and to report to Congress concerning such study. Authorizes appropriations for such study.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 5 January 1981

    Introduced

    Referred to House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 5 January 1981

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 5 January 1981

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 2 February 1981

    Referred

    Referred to Subcommittee on Health.

    Source: Committee

  5. 2 February 1981

    Committee

    For Further Action See H.R.139.

    Source: Committee

  6. 6 February 1981

    Referred

    Referred to Subcommittee on Health and the Environment.

    Source: Committee

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.